Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Enhancement of Macular Pigment Density by Oral Lutein Supplementation

Authors not listed

Insel Gruppe AG, University Hospital Bern · 2007

Abstract

The primary objective of EMPOLS is an increase in macular pigment density (MPD) and contrast sensitivity (CS) after six months supplementation of oral non-compound ester Lutein 10 mg daily, contained in VitaluxPlus®.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2007). Enhancement of Macular Pigment Density by Oral Lutein Supplementation. <em>Insel Gruppe AG, University Hospital Bern</em>. https://clinicaltrials.gov/study/NCT00563979
Vancouver
Anonymous. Enhancement of Macular Pigment Density by Oral Lutein Supplementation. Insel Gruppe AG, University Hospital Bern. 2007.
BibTeX
@misc{anon2007Enhanc, title = {Enhancement of Macular Pigment Density by Oral Lutein Supplementation}, author = {Anonymous}, journal = {Insel Gruppe AG, University Hospital Bern}, year = {2007}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings